IAN.CN - iAnthus Capital Holdings, Inc.

iAnthus Capital Holdings, Inc.

420 Lexington Avenue
Suite 414
New York, NY 10170
United States
646 518 9411
https://www.ianthus.com

Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 840

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Robert R. Galvin	Interim CEO & COO	675k	N/A	1961
Mr. Philippe Faraut	Chief Financial Officer	316.05k	N/A	1970
Ms. Megan W. Kulick CFA	VP of Investor Relations	N/A	N/A	N/A
Mr. Andrew R. Ryan Esq.	Gen. Counsel	N/A	N/A	N/A
Mr. Michael R. Woolston	Sr. VP of Manufacturing, Supply Chain & Quality	N/A	N/A	N/A

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

iAnthus Capital Holdings, Inc. owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States. It offers biomass products, such as pre-rolls; cannabis infused products, including topical creams and edibles; vape cartridges, concentrates, live resins, wax products, oils, and tinctures; cannabidiol products, such as topical creams, tinctures, and sprays, as well as products for beauty and skincare that include lotions, creams, haircare products, lip balms, and bath bombs. The company engages in the wholesale-distribution and retail of CBD products. iAnthus Capital Holdings, Inc. was founded in 2014 and is headquartered in New York, New York.

Corporate Governance

iAnthus Capital Holdings, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.